Nideolo (Dimethyl Fumarate)

Dimethyl Fumarate, the active ingredient in Nideolo, is an Immunomodulator presented as an oral formulation for oral use. It is used to treat multiple sclerosis and psoriasis in adult patients.

GNH USA supplies Nideolo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dimethyl Fumarate acts on immune pathways that are central to inflammatory demyelinating and skin disorders. - Multiple sclerosis: reduces relapse frequency and slows disease progression. - Relapsing‑remitting multiple sclerosis: decreases inflammatory activity in the central nervous system. - Psoriasis: improves skin lesions and reduces disease severity.

Dimethyl Fumarate is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Flushing: transient reddening of the skin, often on the face or neck. - Gastrointestinal discomfort: nausea, abdominal pain, or diarrhea. - Lymphopenia: mild reduction in peripheral lymphocyte count. - Headache: mild to moderate intensity. - Upper respiratory tract infection: common cold‑like symptoms.

Serious or Rare Side Effects: - Severe lymphopenia: marked decrease in lymphocytes increasing infection risk. - Progressive multifocal leukoencephalopathy (PML): rare opportunistic brain infection. - Hepatic injury: elevated liver enzymes or hepatitis. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Acute pancreatitis: abdominal pain with elevated enzymes.

When prescribing Dimethyl Fumarate, clinicians should consider several safety measures. - Monitor lymphocyte counts: check baseline and periodic CBC to detect lymphopenia. - Assess liver function: perform baseline and periodic liver enzyme tests. - Avoid in active infection: defer treatment until infection resolves. - Use caution in renal impairment: adjust monitoring as needed. - Pregnancy and breastfeeding: safety unknown; discuss risks with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Dimethyl Fumarate may interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid): - Immunosuppressants: combined use may increase infection risk. - Live vaccines: administration while on therapy can lead to uncontrolled infection. - Antiepileptic drugs (e.g., carbamazepine): may reduce Dimethyl Fumarate efficacy.

Moderate Interactions (Monitor Closely): - Antacids: may affect gastrointestinal absorption. - Statins: monitor liver enzymes for additive hepatotoxicity. - Alcohol: can exacerbate flushing and gastrointestinal irritation.